Statistics for 6820 Assessing The Efficacy And Safety Of Setrusumab For Osteogenesis Imperfecta: Updated Phase 2 Data From The Phase 2/3 Orbit Study
Total visits
| views | |
|---|---|
| 6820 Assessing The Efficacy And Safety Of Setrusumab For Osteogenesis Imperfecta: Updated Phase 2 Data From The Phase 2/3 Orbit Study | 0 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:52d46f2e-1f08-4ce7-9910-1bffd5283e9c | 15 |
| java.util.UUID:138cb19f-90b3-45f9-83aa-4a434d552fce | 9 |
| Gottesman2024Assessing-CCBYNCND.pdf | 2 |
| java.util.UUID:f6c1d185-62eb-4887-9366-fb1a61ca51ea | 1 |